Irbesartan Cristers

Irbesartan, the active ingredient in Irbesartan Cristers, is an angiotensin II receptor blocker (ARB) presented as an oral tablet for oral use. It treats hypertension and diabetic nephropathy in adult patients, helping to lower blood pressure and protect kidney function.

GNH USA supplies Irbesartan Cristers as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from comprehensive regulatory support and consistent product availability across multiple markets.

Irbesartan is used to manage conditions related to the renin‑angiotensin system, primarily affecting blood pressure and kidney health. - Hypertension: reduces systolic and diastolic blood pressure, improving cardiovascular risk. - Diabetic nephropathy: slows progression of kidney damage in patients with type 2 diabetes. - Chronic kidney disease: helps control blood pressure and proteinuria, supporting renal function preservation. - Heart failure: assists in blood pressure control and reduces cardiac workload in selected patients.

Irbesartan may be associated with a range of adverse reactions, varying from mild to serious. Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Headache: mild to moderate pain in the head region. - Fatigue: feeling unusually tired or weak. Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue or throat that can impair breathing. - Hyperkalemia: elevated blood potassium levels that may cause cardiac rhythm disturbances. - Acute kidney injury: sudden decline in renal function requiring medical attention.

When prescribing Irbesartan, clinicians should consider several precautionary measures to ensure safe use. - Monitor blood pressure: check regularly to avoid hypotension. - Assess renal function: evaluate serum creatinine and eGFR before and during therapy. - Check serum potassium: hyperkalemia risk requires periodic potassium testing. - Use caution in hepatic impairment: dose adjustment may be needed in severe liver disease. - Avoid use in pregnancy: drug may harm the fetus; discontinue if pregnancy is confirmed. - Store at below 25°C: keep in the original container, protect from moisture and light.

Irbesartan can interact with other medicines, altering its efficacy or safety profile. Major Interactions (Avoid): - Aliskiren (in diabetes): combined use may increase risk of renal impairment and hyperkalemia. - ACE inhibitors or other ARBs: concurrent use can cause excessive potassium rise and kidney dysfunction. - Potassium‑sparing diuretics: may lead to dangerous hyperkalemia. Moderate Interactions (Monitor Closely): - NSAIDs: can reduce antihypertensive effect and worsen renal function. - Lithium: Irbesartan may increase lithium concentrations, requiring level monitoring.